A series of 2-acylpyridine thiosemicarbazones was evaluated in vitro against a chloroquine-resistant Plasmodium falciparum strain. Antimalarial activity was assessed by the inhibition of uptake of [G-3H]hypoxanthine by the parasites. Among the mono-and disubstituted derivatives tested, 13 of 17 had 50o inhibitory doses of less than 10 ng/ml. Increasing the size of the ring at N4 from four to five, six, and seven members produced concomitant decreases in activity. Similarly, increasing the size of the aliphatic substituent on the azomethine carbon reduced activity. Selected compounds were also tested against a chloroquine-susceptible strain. The results suggested that the activities of these agents were not modified significantly by resistance to chloroquine. In general, in vitro activities correlate poorly with the in vivo activities in mice infected with Plasmodium berghei. Klayman et al. (6, 7) have shown that 2-acetylpyridine thiosemicarbazones exhibit antimalarial activity in mice infected with Plasmodium berghei. In these studies, the alkylidene group attached to the 2 position of the pyridine ring was critical for antimalarial activity; all 3-and 4-pyridyl compounds were found to be inactive. Activity was also limited to those compounds in which a thiocarbonyl, rather than a carbonyl group, is present. Whereas two N4-monosubstituted 2-acetylpyridine thiosemicarbazones exhibited curative action at a dose level of 160 mg/kg, the incorporation of the N4 nitrogen atom into a six-or seven-membered ring produced cures at doses as low as 20 mg/kg.
A series of 2-acylpyridine thiosemicarbazones was evaluated in vitro against a chloroquine-resistant Plasmodium falciparum strain. Antimalarial activity was assessed by the inhibition of uptake of [G-3H] hypoxanthine by the parasites. Among the mono-and disubstituted derivatives tested, 13 of 17 had 50o inhibitory doses of less than 10 ng/ml. Increasing the size of the ring at N4 from four to five, six, and seven members produced concomitant decreases in activity. Similarly, increasing the size of the aliphatic substituent on the azomethine carbon reduced activity. Selected compounds were also tested against a chloroquine-susceptible strain. The results suggested that the activities of these agents were not modified significantly by resistance to chloroquine. In general, in vitro activities correlate poorly with the in vivo activities in mice infected with Plasmodium berghei.
Klayman et al. (6, 7) have shown that 2-acetylpyridine thiosemicarbazones exhibit antimalarial activity in mice infected with Plasmodium berghei. In these studies, the alkylidene group attached to the 2 position of the pyridine ring was critical for antimalarial activity; all 3-and 4-pyridyl compounds were found to be inactive. Activity was also limited to those compounds in which a thiocarbonyl, rather than a carbonyl group, is present. Whereas two N4-monosubstituted 2-acetylpyridine thiosemicarbazones exhibited curative action at a dose level of 160 mg/kg, the incorporation of the N4 nitrogen atom into a six-or seven-membered ring produced cures at doses as low as 20 mg/kg.
The present study was undertaken to evaluate in vitro activity in a series of 2-acylpyridine thiosemicarbazones against selected strains of Plasmodium falciparum. Due to the emerging clinical importance of multidrug resistance, major emphasis is placed on the activity of these compounds against a chloroquine-resistant strain. To determine whether resistance to chloroquine compromised the activities of these agents, selected compounds were tested against a chloroquine-susceptible strain. An attempt has been made to correlate these in vitro data with in vivo activities of these compounds against P. berghei infections in mice.
MATERLALS AND METHODS Antimalarial activity against P. falciparum was determined by using the semiautomated in vitro system described by Desjardins et al. (4) .
Parasite. The multi-drug-resistant Vietnam Smith strain (2) was obtained from a military volunteer at Ft. Stock cultures were grown with 6% human A+ erythrocytes in RPMI 1640 medium supplemented with 10%o heat-inactivated human A+ plasma in 25-ml tissue culture flasks (4); total volume was 5.0 ml. The cultures were maintained under a gas phase of 5% O2-5% CO2-909o N2 (5) and incubated at 37°C.
Preparation of compounds. The thiosemicarbazones tested were synthesized in the Organic Synthesis Section of the Walter Reed Army Institute of Research. All compounds were initially dissolved in a 50/50 (vol/vol) mixture of dimethyl sulfoxide (Fisher) and ethanol to a concentration of 1 mg/ml. Subsequent dilutions were made with culture medium. The final dilution contained less than 0.02% dimethyl sulfoxide or ethanol, which we have determined to have no effect on the parasites in culture.
Preparation of isotope. [G-3H]hypoxanthine (New England Nuclear Corp., Boston, Mass.; 10 Ci/mmol), supplied as a sterile aqueous solution, was diluted in culture medium to a concentration of 10 ,Ci/ml. Twenty-five microliters of this solution was added to each well of a 96-well microtiter plate. Incorporation of radioactivity by the parasites served as an index of parasite viability (4) .
Preparation of microtiter plates and harvesting of parasites. The preparation of microtiter plates and harvest of parasites were performed as previously described (4) . Each drug was serially diluted 2-fold for a total of seven concentrations over a 64-fold range. The final hematocrit in each well was 1%, and parasitemia was 0.4 to 0.6%. Four wells of each microtiter plate contained chloroquine and mefloquine as controls. The plates were placed in an airtight box, flushed with a gas mixture of 5% O°-5% C02-90%o N2 and placed in an incubator at 37°C for 24 h. After this time Chloroquine (2H3PO4) 60 ± 6.6 (n = 10) 7.6 ± 1.6 (n = 5) Mefloquine (HCI) 2.5 ± 0.46 (n = 10) 3.5 ± 0.82 (n = 5) Pyrimethamine >68 (n = 2) >68 (n = 2) interval, the plates were taken out of the box, and to each well was added [G-'H]hypoxanthine. The plates were replaced in the airtight box, gassed, and incubated for an additional 18 h. The contents from each well were then collected on ifiter paper with a MASH II harvester (Microbiological Associates, Bethesda, Md.). The ifiter paper was dried at 80°C for 60 min in a drying oven.
Sintillation counting. Dried filter disks were individually placed in minivials (Bio-Vial; Beckman Instruments, Inc., Irvine, Calif.) with 1.5 ml of Aquasol-2 (New England Nuclear Corp.) xylene-based scintillation fluid. Radioactivity was assayed in a Searle Delta 300 scintillation spectrometer to a counting error of less than 1%. Data analysis. The resulting counts per minute were substituent produced a concomitant reduction in activity. Activities of selected compounds against the chloroquine-susceptible Camp strain produced a dichotomy of results as compared to the Smith strain. A striking difference in the activities of compound 12 was noted, whereas modest differences were observed with compounds 11 and 37. Comparable activities were evident among the remaining compounds tested.
In vivo activity. Six Thirteen of seventeen compounds among the mono-and disubstituted (noncyclic) derivatives had ID50s of less than 10 ng/ml against P. falciparum, but against P. berghei the majority of these compounds were either toxic at low levels or inactive.
The most active among the cyclic-substituted 2-acetylpyridine thiosemicarbazones against the Smith strain was the four-member compound 17; a progressive increase in ring size substitutions was paralleled by decreasing activity ( Increasing the size of the substituent attached to the azomethine carbon (R1 substitution) resulted in a diminution of activity against P. falciparum. This was evident in compounds 30, 31, and 32, in which N4 is incorporated into a seven-member ring. As R1 was changed from a hydrogen to methyl and then to ethyl, the respective ID50s increased from 3.1 to 31 ng/ml. This was also observed for compounds with N4 incorporated either into a six-member ring with a methyl group in the 2 position (compounds 20 and 21) or into an azabicyclononyl moiety (compounds 37 and 38). The compound with R1 = H was considerably more active than that in which R, = CH3. The reverse is true for P. berghei, against which compounds having RI = CH3
were most active.
Based on our findings on the in vitro antimalarial action of a series of 2-acylpyridine thiosemicarbazones against chloroquine-resistant P. falciparum, these compounds warrant further definitive investigations. Perhaps a select few could be introduced into the Aotus trivirgatus-P. falciparum in vivo model (1) to fully ascertain their potential as possible antimalarial agents. Although many of these compounds exhibited toxicity for mice at low doses, some had activities against P. berghei greater than that of mefloquine (calculated CD50, 120 mg/kg).
These analyses of structure-activity relationships should serve as a guide for synthesis and investigations of additional analogs. Newer and more effective drugs are required because of the relentless emergence of strains of human plasmodia (especially P. falciparum) resistant to currently available antimalaria drugs.
